Cover Image
市場調查報告書

市場、接種者人口資料 (成人、幼兒) 及疫苗品牌分析流感疫苗的歐洲市場預測:23個國家

Europe Influenza Vaccine Market & Forecast (23 Countries Market & Vaccinated Population Data) By Pediatrics and Adult, & Vaccine Brands Analysis

出版商 Renub Research 商品編碼 493370
出版日期 內容資訊 英文 301 Pages; 300 Figures; 8 Tables
商品交期: 最快1-2個工作天內
價格
Back to Top
市場、接種者人口資料 (成人、幼兒) 及疫苗品牌分析流感疫苗的歐洲市場預測:23個國家 Europe Influenza Vaccine Market & Forecast (23 Countries Market & Vaccinated Population Data) By Pediatrics and Adult, & Vaccine Brands Analysis
出版日期: 2017年04月17日 內容資訊: 英文 301 Pages; 300 Figures; 8 Tables
簡介

歐洲的流感疫苗的市場規模估計約10億美元。

本報告提供歐洲的流感疫苗的市場調查,流感病毒種類與概要,全球流感疫苗接種者人口及市場規模的變化與預測,成人、幼兒的明細,各主要國家分析,領導品牌的銷售額預測,市場促進因素及課題分析等彙整資料。

第1章 摘要整理

第2章 流感:簡介

  • 流感病毒的各種類型
    • A型
    • B型
    • C型
    • D型
  • 流感大流行 (新型流感)

第3章 流感病毒結構

第4章 主要流感大流行病

第5章 歐洲的流感疫苗接種者人口

  • 季節性流感幼兒疫苗接種者數
  • 季節性流感成人疫苗接種者數

第6章 歐洲的季節性流感疫苗市場

  • 季節性流感幼兒用疫苗市場
  • 季節性流感成人用疫苗市場

第7章 歐洲的季節性流感疫苗的市場佔有率分析

  • 季節性流感疫苗的市場佔有率
  • 季節性流感幼兒用疫苗的市場佔有率
  • 季節性流感成人用疫苗的市場佔有率

第8-30章 各國分析

  • 荷蘭
  • 丹麥
  • 愛沙尼亞
  • 芬蘭
  • 德國
  • 法國
  • 匈牙利
  • 冰島
  • 愛爾蘭
  • 義大利
  • 拉脫維亞
  • 立陶宛
  • 盧森堡
  • 馬爾他
  • 挪威
  • 波蘭
  • 葡萄牙
  • 羅馬尼亞
  • 斯洛伐克
  • 斯洛維尼亞
  • 西班牙
  • 瑞典
  • 英國
    • 疫苗接種者數
      • 幼兒
      • 成人
    • 疫苗市場
      • 幼兒
      • 成人

第31章 全球季節性流感疫苗品牌的銷售額預測

  • Vaxigrip / Fluzone
  • Fluarix / Flulaval
  • FluMist/Fluenz
  • Afluria / Fluvax and Fluvirin / Flucelvax
  • Anflu

第32章 季節性流感疫苗:促進成長要素

第33章 季節性流感疫苗:課題

圖表

目錄

Europe Influenza Vaccine Market was close to US$ 1 Billion . United Kingdom holds the highest seasonal influenza vaccine market share. United Kingdom, Germany, France, Italy & Spain together holds more than 80 percent of influenza vaccine market share. In children vaccine market, United Kingdom is the leader and France holds the second spot. In adult vaccine market United Kingdom and Germany have a close fight for top slot.

Europe Influenza Vaccine Market & Forecast (23 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis is the 7th report by Renub Research on Influenza Vaccine Market. This 301 page report with 300 Figures and 8 Tables covers 23 European countries Influenza Vaccine Market in Children and Adult, its Influenza Vaccinated Population Numbers in Children and Adult. All 23 European countries have been extensively studied from six points:

  • 1. Seasonal Influenza Vaccinated Population & Forecast
  • 2. Seasonal Influenza Child Vaccinated Population & Forecast
  • 3. Seasonal Adult Influenza Vaccinated Population & Forecast
  • 4. Seasonal Influenza Vaccine Market
  • 5. Seasonal Child Influenza Vaccine Market
  • 6. Seasonal Adult Influenza Vaccine Market

Scope of Study

  • Influenza Vaccine Market & Forecast has been sub divided into two segments Children Influenza Vaccine Market & Forecast and Adult Influenza Vaccine Market & Forecast.
  • Influenza Vaccine Market share & Forecast, Children Influenza Vaccine Market share & Forecast and Adult Influenza Vaccine Market share & Forecast.
  • Influenza Vaccinated Population & Forecast has been sub divided into two segments Children Influenza Vaccinated Population & Forecast and Adult Influenza Vaccinated Population & Forecast.
  • Influenza Vaccine Brand Sales and Forecast

This report offers the best viewpoint on the leading five influenza vaccine brands

  • 1. Vaxigrip/Fluzone
  • 2. Fluarix/ Flulaval
  • 3. FluMist/Fluenz
  • 4. Afluria/Fluvax and Fluvirin/Flucelvax
  • 5. Anflu

23 Countries covered in the report are as follows

  • 1. Netherlands
  • 2. Denmark
  • 3. Estonia
  • 4. Finland
  • 5. Germany
  • 6. France
  • 7. Hungary
  • 8. Iceland
  • 9. Ireland
  • 10. Italy
  • 11. Latvia
  • 12. Lithuania
  • 13. Luxembourg
  • 14. Malta
  • 15. Norway
  • 16. Poland
  • 17. Portugal
  • 18. Romania
  • 19. Slovakia
  • 20. Slovenia
  • 21. Spain
  • 22. Sweden
  • 23. United Kingdom

This report is a combination of 5 reports

  • 1. Influenza Vaccine Market in Italy, Malta, Portugal and Spain
  • 2. Influenza Vaccine Market & Forecast in West Europe
  • 3. Nordics Seasonal Influenza Vaccine Market Forecast
  • 4. Seasonal Influenza Vaccination Market in Hungary, Romania, Slovakia and Slovenia
  • 5. Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia

Table of Contents

1. Executive Summary

2. Influenza - Introduction

  • 2.1 Different types of influenza viruses
    • 2.1.1 Type A Flu Virus
    • 2.1.2 Type B Flu Virus
    • 2.1.3 Type C Flu Virus
    • 2.1.4 Type D Flu Virus
  • 2.2 An influenza pandemic

3. Structure of Influenza Virus

4. Notable Influenza Pandemics

5. Europe - Seasonal Influenza Vaccinated Population

  • 5.1 Europe - Seasonal Influenza Vaccinated Child Population
  • 5.2 Europe - Seasonal Influenza Vaccinated Adult Population

6. Europe - Seasonal Influenza Vaccine Market

  • 6.1 Europe - Seasonal Influenza Child Vaccine Market
  • 6.2 Europe - Seasonal Influenza Adult Vaccine Market

7. Europe - Seasonal Influenza Vaccine Market Share Analysis

  • 7.1 Europe - Seasonal Influenza Vaccine Market Share
  • 7.2 Europe - Seasonal Influenza Child Vaccine Market Share
  • 7.3 Europe - Seasonal Influenza Adult Vaccine Market Share

8. Netherlands

  • 8.1 Netherlands Seasonal Influenza Vaccinated Total Population
    • 8.1.1 Netherlands Seasonal Influenza Vaccinated Child Population
    • 8.1.2 Netherlands Seasonal Influenza Vaccinated Adult Population
  • 8.2 Netherlands Seasonal Influenza Vaccine Market
    • 8.2.1 Netherlands Seasonal Influenza Child Vaccine Market
    • 8.2.2 Netherlands Seasonal Influenza Adult Vaccine Market

9. Denmark

  • 9.1 Denmark Seasonal Influenza Vaccinated Total Population
    • 9.1.1 Denmark Seasonal Influenza Vaccinated Child Population
    • 9.1.2 Denmark Seasonal Influenza Vaccinated Adult Population
  • 9.2 Denmark Seasonal Influenza Vaccine Market
    • 9.2.1 Denmark Seasonal Influenza Child Vaccine Market
    • 9.2.2 Denmark Seasonal Influenza Adult Vaccine Market

10. Estonia

  • 10.1 Estonia Seasonal Influenza Vaccinated Total Population
    • 10.1.1 Estonia Seasonal Influenza Vaccinated Child Population
    • 10.1.2 Estonia Seasonal Influenza Vaccinated Adult Population
  • 10.2 Estonia Seasonal Influenza Vaccine Market
    • 10.2.1 Estonia Seasonal Influenza Child Vaccine Market
    • 10.2.2 Estonia Seasonal Influenza Adult Vaccine Market

11. Finland

  • 11.1 Finland Seasonal Influenza Vaccinated Total Population
    • 11.1.1 Finland Seasonal Influenza Vaccinated Child Population
    • 11.1.2 Finland Seasonal Influenza Vaccinated Adult Population
  • 11.2 Finland Seasonal Influenza Vaccine Market
    • 11.2.1 Finland Seasonal Influenza Child Vaccine Market
    • 11.2.2 Finland Seasonal Influenza Adult Vaccine Market

12. Germany

  • 12.1 Germany Seasonal Influenza Vaccinated Total Population
    • 12.1.1 Germany Seasonal Influenza Vaccinated Child Population
    • 12.1.2 Germany Seasonal Influenza Vaccinated Adult Population
  • 12.2 Germany Seasonal Influenza Vaccine Market
    • 12.2.1 Germany Seasonal Influenza Child Vaccine Market
    • 12.2.2 Germany Seasonal Influenza Adult Vaccine Market

13. France

  • 13.1 France Seasonal Influenza Vaccinated Total Population
    • 13.1.1 France Seasonal Influenza Vaccinated Child Population
    • 13.1.2 France Seasonal Influenza Vaccinated Adult Population
  • 13.2 France Seasonal Influenza Vaccine Market Analysis
    • 13.2.1 France Seasonal Influenza Child Vaccine Market
    • 13.2.2 France Seasonal Influenza Adult Vaccine Market

14. Hungary

  • 14.1 Hungary Seasonal Influenza Vaccinated Total Population
    • 14.1.1 Hungary Seasonal Influenza Vaccinated Child Population
    • 14.1.2 Hungary Seasonal Influenza Vaccinated Adult Population
  • 14.2 Hungary Seasonal Influenza Vaccine Market
    • 14.2.1 Hungary Seasonal Influenza Child Vaccine Market
    • 14.2.2 Hungary Seasonal Influenza Adult Vaccine Market

15. Iceland

  • 15.1 Iceland Seasonal Influenza Vaccinated Total Population
    • 15.1.1 Iceland Seasonal Influenza Vaccinated Child Population
    • 15.1.2 Iceland Seasonal Influenza Vaccinated Adult Population
  • 15.2 Iceland Seasonal Influenza Vaccine Market
    • 15.2.1 Iceland Seasonal Influenza Child Vaccine Market
    • 15.2.2 Iceland Seasonal Influenza Adult Vaccine Market

16. Ireland

  • 16.1 Ireland Seasonal Influenza Vaccinated Total Population
    • 16.1.1 Ireland Seasonal Influenza Vaccinated Child Population
    • 16.1.2 Ireland Seasonal Influenza Vaccinated Adult Population
  • 16.2 Ireland Seasonal Influenza Vaccine Market
    • 16.2.1 Ireland Seasonal Influenza Child Vaccine Market
    • 16.2.2 Ireland Seasonal Influenza Adult Vaccine Market

17. Italy

  • 17.1 Italy Seasonal Influenza Vaccinated Total Population
    • 17.1.1 Italy Seasonal Influenza Vaccinated Child Population
    • 17.1.2 Italy Seasonal Influenza Vaccinated Adult Population
  • 17.2 Italy Seasonal Influenza Vaccine Market
    • 17.2.1 Italy Seasonal Influenza Child Vaccine Market
    • 17.2.2 Italy Seasonal Influenza Adult Vaccine Market

18. Latvia

  • 18.1 Latvia Seasonal Influenza Vaccinated Total Population
    • 18.1.1 Latvia Seasonal Influenza Vaccinated Child Population
    • 18.1.2 Latvia Seasonal Influenza Vaccinated Adult Population
  • 18.2 Latvia Seasonal Influenza Vaccine Market
    • 18.2.1 Latvia Seasonal Influenza Child Vaccine Market
    • 18.2.2 Latvia Seasonal Influenza Adult Vaccine Market

19. Lithuania

  • 19.1 Lithuania Seasonal Influenza Vaccinated Total Population
    • 19.1.1 Lithuania Seasonal Influenza Vaccinated Child Population
    • 19.1.2 Lithuania Seasonal Influenza Vaccinated Adult Population
  • 19.2 Lithuania Seasonal Influenza Vaccine Market
    • 19.2.1 Lithuania Seasonal Influenza Child Vaccine Market
    • 19.2.2 Lithuania Seasonal Influenza Adult Vaccine Market

20. Luxembourg

  • 20.1 Luxembourg Seasonal Influenza Vaccinated Total Population
    • 20.1.1 Luxembourg Seasonal Influenza Vaccinated Child Population
    • 20.1.2 Luxembourg Seasonal Influenza Vaccinated Adult Population
  • 20.2 Luxembourg Seasonal Influenza Vaccine Market
    • 20.2.1 Luxembourg Seasonal Influenza Child Vaccine Market
    • 20.2.2 Luxembourg Seasonal Influenza Adult Vaccine Market

21. Malta

  • 21.1 Malta Seasonal Influenza Vaccinated Total Population
    • 21.1.1 Malta Seasonal Influenza Vaccinated Child Population
    • 21.1.2 Malta Seasonal Influenza Vaccinated Adult Population
  • 21.2 Malta Seasonal Influenza Vaccine Market
    • 21.2.1 Malta Seasonal Influenza Child Vaccine Market
    • 21.2.2 Malta Seasonal Influenza Adult Vaccine Market

22. Norway

  • 22.1 Norway Seasonal Influenza Vaccinated Total Population
    • 22.1.1 Norway Seasonal Influenza Vaccinated Child Population
    • 22.1.2 Norway Seasonal Influenza Vaccinated Adult Population
  • 22.2 Norway Seasonal Influenza Vaccine Market
    • 22.2.1 Norway Seasonal Influenza Child Vaccine Market
    • 22.2.2 Norway Seasonal Influenza Adult Vaccine Market

23. Poland

  • 23.1 Poland Seasonal Influenza Vaccinated Total Population
    • 23.1.1 Poland Seasonal Influenza Vaccinated Child Population
    • 23.1.2 Poland Seasonal Influenza Vaccinated Adult Population
  • 23.2 Poland Seasonal Influenza Vaccine Market
    • 23.2.1 Poland Seasonal Influenza Child Vaccine Market
    • 23.2.2 Poland Seasonal Influenza Adult Vaccine Market

24. Portugal

  • 24.1 Portugal Seasonal Influenza Vaccinated Total Population
    • 24.1.1 Portugal Seasonal Influenza Vaccinated Child Population
    • 24.1.2 Portugal Seasonal Influenza Vaccinated Adult Population
  • 24.2 Portugal Seasonal Influenza Vaccine Market
    • 24.2.1 Portugal Seasonal Influenza Child Vaccine Market
    • 24.2.2 Portugal Seasonal Influenza Adult Vaccine Market

25. Romania

  • 25.1 Romania Seasonal Influenza Vaccinated Total Population
    • 25.1.1 Romania Seasonal Influenza Vaccinated Child Population
    • 25.1.2 Romania Seasonal Influenza Vaccinated Adult Population
  • 25.2 Romania Seasonal Influenza Vaccine Market
    • 25.2.1 Romania Seasonal Influenza Child Vaccine Market
    • 25.2.2 Romania Seasonal Influenza Adult Vaccine Market

26. Slovakia

  • 26.1 Slovakia Seasonal Influenza Vaccinated Total Population
    • 26.1.1 Slovakia Seasonal Influenza Vaccinated Child Population
    • 26.1.2 Slovakia Seasonal Influenza Vaccinated Adult Population
  • 26.2 Slovakia Seasonal Influenza Vaccine Market
    • 26.2.1 Slovakia Seasonal Influenza Child Vaccine Market
    • 26.2.2 Slovakia Seasonal Influenza Adult Vaccine Market

27. Slovenia

  • 27.1 Slovenia Seasonal Influenza Vaccinated Total Population
    • 27.1.1 Slovenia Seasonal Influenza Vaccinated Child Population
    • 27.1.2 Slovenia Seasonal Influenza Vaccinated Adult Population
  • 27.2 Slovenia Seasonal Influenza Vaccine Market
    • 27.2.1 Slovenia Seasonal Influenza Child Vaccine Market
    • 27.2.2 Slovenia Seasonal Influenza Adult Vaccine Market

28. Spain

  • 28.1 Spain Seasonal Influenza Vaccinated Total Population
    • 28.1.1 Spain Seasonal Influenza Vaccinated Child Population
    • 28.1.2 Spain Seasonal Influenza Vaccinated Adult Population
  • 28.2 Spain Seasonal Influenza Vaccine Market
    • 28.2.1 Spain Seasonal Influenza Child Vaccine Market
    • 28.2.2 Spain Seasonal Influenza Adult Vaccine Market

29. Sweden

  • 29.1 Sweden Seasonal Influenza Vaccinated Total Population
    • 29.1.1 Sweden Seasonal Influenza Vaccinated Child Population
    • 29.1.2 Sweden Seasonal Influenza Vaccinated Adult Population
  • 29.2 Sweden Seasonal Influenza Vaccine Market
    • 29.2.1 Sweden Seasonal Influenza Child Vaccine Market
    • 29.2.2 Sweden Seasonal Influenza Adult Vaccine Market

30. United Kingdom

  • 30.1 United Kingdom Seasonal Influenza Vaccinated Total Population
    • 30.1.1 United Kingdom Seasonal Influenza Vaccinated Child Population
    • 30.1.2 United Kingdom Seasonal Influenza Vaccinated Adult Population
  • 30.2 United Kingdom Seasonal Influenza Vaccine Market
    • 30.2.1 United Kingdom Seasonal Influenza Child Vaccine Market
    • 30.2.2 United Kingdom Seasonal Influenza Adult Vaccine Market

31. Worldwide - Seasonal Influenza Vaccine Brand Sales and Forecast

  • 31.1 Vaxigrip / Fluzone Vaccine Sales and Forecast
  • 31.2 Fluarix / Flulaval Vaccine Sales and Forecast
  • 31.3 FluMist / Fluenz Vaccine Sales and Forecast
  • 31.4 Afluria / Fluvax and Fluvirin / Flucelvax Vaccine Sales and Forecast
  • 31.5 Anflu Vaccine Sales and Forecast

32. Seasonal Influenza Vaccine - Growth Drivers

  • 32.1 Increasing Awareness on Seasonal Influenza Vaccination
  • 32.2 Vaccine Producers Plan to Boost Flu Vaccine Production
  • 32.3 Increasing Healthcare Expenditure Share in GDP of European Countries

33. Seasonal Influenza Vaccine - Challenges

  • 33.1 Regulatory Challenges with New and Novel Influenza Vaccines
  • 33.2 Absences of Proper Healthcare Infrastructure
  • 33.3 Partial Reimbursement and Access to the Vaccines

List of Figures

  • Figure 3 1: Structure of Influenza Virus
  • Figure 5 1: Europe - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
  • Figure 5 2: Europe - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
  • Figure 5 3: Europe - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 5 4: Europe - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 5 5: Europe - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 5 6: Europe - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 6 1: Europe - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 6 2: Europe - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
  • Figure 6 3: Europe - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
  • Figure 6 4: Europe - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
  • Figure 6 5: Europe - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
  • Figure 6 6: Europe - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
  • Figure 8 1: Netherlands - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 8 2: Netherlands - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 8 3: Netherlands - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 8 4: Netherlands - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 8 5: Netherlands - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 8 6: Netherlands - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 8 7: Netherlands - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 8 8: Netherlands - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 8 9: Netherlands - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 8 10: Netherlands - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 8 11: Netherlands - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 8 12: Netherlands - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 9 1: Denmark - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 9 2: Denmark - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 9 3: Denmark - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 9 4: Denmark - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 9 5: Denmark - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 9 6: Denmark - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 9 7: Denmark - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 9 8: Denmark - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 9 9: Denmark - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 9 10: Denmark - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 9 11: Denmark - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 9 12: Denmark - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 10 1: Estonia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 10 2: Estonia -Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 10 3: Estonia- Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 10 4: Estonia- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 10 5: Estonia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 10 6: Estonia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 10 7: Estonia- Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 10 8: Estonia- Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 10 9: Estonia - Seasonal Influenza Children Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 10 10: Estonia - Forecast for Seasonal Influenza Children Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 10 11: Estonia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 10 12: Estonia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 11 1: Finland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 11 2: Finland - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 11 3: Finland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 11 4: Finland - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 11 5: Finland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 11 6: Finland - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 11 7: Finland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 11 8: Finland - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 11 9: Finland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 11 10: Finland - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 11 11: Finland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 11 12: Finland - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 12 1: Germany - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 12 2: Germany - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 12 3: Germany - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 12 4: Germany - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 12 5: Germany - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 12 6: Germany - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 12 7: Germany - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 12 8: Germany - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
  • Figure 12 9: Germany - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
  • Figure 12 10: Germany - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
  • Figure 12 11: Germany- Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
  • Figure 12 12: Germany- Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
  • Figure 13 1: France - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 13 2: France - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 13 3: France - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 13 4: France- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 13 5: France - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 13 6: France - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 13 7: France - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 13 8: France - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
  • Figure 13 9: France - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
  • Figure 13 10: France - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
  • Figure 13 11: France - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
  • Figure 13 12: France - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
  • Figure 14 1: Hungary - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 14 2: Hungary - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 14 3: Hungary - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 14 4: Hungary - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 14 5: Hungary - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 14 6: Hungary- Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 14 7: Hungary - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 14 8: Hungary - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 14 9: Hungary - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 14 10: Hungary - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 14 11: Hungary - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 14 12: Hungary - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 15 1: Iceland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 15 2: Iceland - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 15 3: Iceland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 15 4: Iceland - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 15 5: Iceland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 15 6: Iceland - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 15 7: Iceland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 15 8: Iceland - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 15 9: Iceland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 15 10: Iceland - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 15 11: Iceland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 15 12: Iceland - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 16 1: Ireland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 16 2: Ireland - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 16 3: Ireland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 16 4: Ireland - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 16 5: Ireland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 16 6: Ireland - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 16 7: Ireland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 16 8: Ireland - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 16 9: Ireland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 16 10: Ireland - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 16 11: Ireland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 16 12: Ireland - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 17 1: Italy - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 17 2: Italy - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 17 3: Italy - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 17 4: Italy - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 17 5: Italy - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 17 6: Italy - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 17 7: Italy - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 17 8: Italy - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
  • Figure 17 9: Italy - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
  • Figure 17 10: Italy - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
  • Figure 17 11: Italy - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
  • Figure 17 12: Italy- Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
  • Figure 18 1: Latvia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 18 2: Latvia - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 18 3: Latvia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 18 4: Latvia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 18 5: Latvia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 18 6: Latvia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 18 7: Latvia- Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 18 8: Latvia- Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 18 9: Latvia- Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 18 10: Latvia- Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 19 1: Lithuania - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 19 2: Lithuania - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 19 3: Lithuania - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 19 4: Lithuania - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 19 5: Lithuania - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 19 6: Lithuania - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 19 7: Lithuania - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 19 8: Lithuania - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 19 9: Lithuania - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 19 10: Lithuania - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 19 11: Lithuania - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 19 12: Lithuania - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 20 1: Luxembourg - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 20 2: Luxembourg - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 20 3: Luxembourg - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 20 4: Luxembourg - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 20 5: Luxembourg - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 20 6: Luxembourg - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 20 7: Luxembourg - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 20 8: Luxembourg - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 20 9: Luxembourg - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 20 10: Luxembourg - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 20 11: Luxembourg - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 -2016
  • Figure 20 12: Luxembourg - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 -2022
  • Figure 21 1: Malta - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 21 2: Malta - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 21 3: Malta - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 21 4: Malta - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 21 5: Malta - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 21 6: Malta - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 21 7: Malta - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 21 8: Malta - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 21 9: Malta - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 21 10: Malta - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 21 11: Malta - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 21 12: Malta - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 22 1: Norway - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 22 2: Norway - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 22 3: Norway - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 22 4: Norway - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 22 5: Norway - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 22 6: Norway - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 22 7: Norway - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 22 8: Norway - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 22 9: Norway - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 22 10: Norway - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 22 11: Norway - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 22 12: Norway - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 23 1: Poland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 23 2: Poland- Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 23 3: Poland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 23 4: Poland - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 23 5: Poland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 23 6: Poland - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 23 7: Poland - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 23 8: Poland - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
  • Figure 23 9: Poland - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
  • Figure 23 10: Poland - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
  • Figure 23 11: Poland - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
  • Figure 23 12: Poland - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017- 2022
  • Figure 24 1: Portugal - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 24 2: Portugal - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 24 3: Portugal - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 24 4: Portugal - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 24 5: Portugal - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 24 6: Portugal - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 24 7: Portugal - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 24 8: Portugal - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
  • Figure 24 9: Portugal - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
  • Figure 24 10: Portugal - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
  • Figure 24 11: Portugal - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
  • Figure 24 12: Portugal - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
  • Figure 25 1: Romania - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 25 2: Romania - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 25 3: Romania - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 25 4: Romania - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 25 5: Romania - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 25 6: Romania - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 25 7: Romania - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 25 8: Romania - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 25 9: Romania - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 25 10: Romania - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 25 11: Romania - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 25 12: Romania - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 26 1: Slovakia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 26 2: Slovakia - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 26 3: Slovakia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 26 4: Slovakia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 26 5: Slovakia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 26 6: Slovakia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 26 7: Slovakia - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 26 8: Slovakia - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 26 9: Slovakia - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 26 10: Slovakia- Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 26 11: Slovakia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 26 12: Slovakia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 27 1: Slovenia - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 27 2: Slovenia - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 27 3: Slovenia - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 27 4: Slovenia - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 27 5: Slovenia - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 27 6: Slovenia - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 27 7: Slovenia - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 27 8: Slovenia - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 27 9: Slovenia - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 27 10: Slovenia - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 27 11: Slovenia - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 27 12: Slovenia - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 28 1: Spain - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 28 2: Spain - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 28 3: Spain - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 28 4: Spain - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 28 5: Spain - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 28 6: Spain - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 28 7: Spain - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 28 8: Spain - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
  • Figure 28 9: Spain -Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
  • Figure 28 10: Spain - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
  • Figure 28 11: Spain - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
  • Figure 28 12: Spain - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
  • Figure 29 1: Sweden - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
  • Figure 29 2: Sweden - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
  • Figure 29 3: Sweden - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 29 4: Sweden - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 29 5: Sweden - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 29 6: Sweden - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 29 7: Sweden - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 29 8: Sweden - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 29 9: Sweden - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 29 10: Sweden - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 29 11: Sweden - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
  • Figure 29 12: Sweden - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
  • Figure 30 1: United Kingdom - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
  • Figure 30 2: United Kingdom - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
  • Figure 30 3: United Kingdom - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
  • Figure 30 4: United Kingdom - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
  • Figure 30 5: United Kingdom - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
  • Figure 30 6: United Kingdom - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
  • Figure 30 7: List of Seasonal Influenza Vaccines for the 2016/17 Influenza Season
  • Figure 30 8: United Kingdom - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 30 9: United Kingdom - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
  • Figure 30 10: United Kingdom - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
  • Figure 30 11: United Kingdom - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
  • Figure 30 12: United Kingdom - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
  • Figure 30 13: United Kingdom - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
  • Figure 31 1: Worldwide - Vaxigrip/Fluzone Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 31 2: Worldwide - Forecast for Vaxigrip/Fluzone Seasonal Influenza Vaccine Market (Million US$), 2017- 2022
  • Figure 31 3: Worldwide - Fluarix / Flulaval Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 31 4: Worldwide - Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Market (Million US$), 2017- 2022
  • Figure 31 5: Worldwide - Flumist/Fluenz Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 31 6: Worldwide - Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
  • Figure 31 7: Worldwide - Afluria / Fluvax and Fluvirin / Flucelvax Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 31 8: Worldwide - Afluria / Fluvax and Fluvirin / Flucelvax Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 31 9: Worldwide - Anflu Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
  • Figure 31 10: Worldwide - Forecast for Anflu Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
  • Figure 32 1: Vaccine Manufacturers - Influenza Vaccine Production (Million Doses), 2013-2015
  • Figure 33 1: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019

List of Tables

  • Table 4 1: Notable Influenza Pandemics
  • Table 7 1: Europe - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
  • Table 7 2: Europe - Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
  • Table 7 3: Europe - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
  • Table 7 4: Europe - Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
  • Table 7 5: Europe - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
  • Table 7 6: Europe - Forecast for Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
  • Table 32 1: Europe - Healthcare Expenditure Share (Percent) of GDP, 2005 - 2015
Back to Top